New horizons in the management of advanced colorectal cancer
Bayer mCRC Expert Forum Meeting

Stivarga® (regorafenib) Prescribing Information
Join our Expert Faculty as they share best practices for managing patients with mCRC using currently available treatment options, including STIVARGA® (regorafenib), and address the key challenges clinician’s face in today’s ever-evolving treatment landscape. In the videos below, our faculty members share their own real-world experiences and provide valuable insights from the latest congress data and innovations.
Watch the individual speaker sessions now:
- Dr Sheela Rao – The current treatment landscape: Metastatic Colorectal Cancer
- Professor Gary Middleton – Colorectal cancer - ASCO 2024 Highlights
- Dr Alice Dewdney – Renewed hope for patients who have progressed after IV chemotherapy
- Dr Paul Ross – Practicalities of using STIVARGA
- Dr Lennard Lee – The Pinnacle or False summit: Where are we in 2024 for the national cancer vaccine advance
This video series is organised and funded by Bayer plc.
PP-STI-GB-0417 | February 2025